Lilly put forward as ImClone's mystery suitor
This article was originally published in Scrip
Executive Summary
Speculation is mounting that Lilly is the mystery suitor for ImClone Systems, piling further pressure on Bristol-Myers Squibb's ongoing attempts to buy the US biotech company.